Now that certain strains of H5N1 have infected not only birds but also animals, vaccine manufacturers have said they could develop hundreds of millions of doses of bird flu vaccine for humans within months if a new strain of avian influenza were to begin infecting human beings.
Moderna had been working on an experimental mRNA pandemic influenza vaccine prior to 2020 that was modified to create the COVID vaccine, and Moderna officials report the company plans a small human trial of an mRNA pandemic flu vaccine in 2023 that will contain the new H5N1 subtype.
A GSK spokesperson said the company was awarded contracts with the United States, Canada, the European Union and the World Health Organization to supply a vaccine in the event of a potential bird flu pandemic.
Yahoo Finance Mar. 20, 2023.2 Rigby J. Vaccine makers prep bird flu shot for humans 'just in case'; rich nations lock in supplies.
Reuters Mar. 20, 2023.3 Morrison C. Vaccine makers say they're 'standing ready' for human bird flu pandemic: Moderna, GSK and Sanofi all prepare to roll out H5N1 shots as fears mount about zoonotic spillover.
WXYZ Detroit Mar. 21, 2023.5 Morrison C. Vaccine makers say they're 'standing ready' for human bird flu pandemic: Moderna, GSK and Sanofi all prepare to roll out H5N1 shots as fears mount about zoonotic spillover.
Human Vaccines & Immunotherapeutics 2018; 14(8): 1874-1882.9 Morrison C. Vaccine makers say they're 'standing ready' for human bird flu pandemic: Moderna, GSK and Sanofi all prepare to roll out H5N1 shots as fears mount about zoonotic spillover.
No comments:
Post a Comment